Ventricular Assist Devices Market Report 2021-26: Industry Growth, Trends and Forecast 2021-2026


According to the latest report by IMARC Group, titled “Ventricular Assist Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global ventricular assist devices market size reached US$ 1.6 Billion in 2019. Also known as a mechanical circulatory support device, a ventricular assist device (VAD) is an implantable mechanical pump utilized to support heart function and blood flow among patients with a weak heart or those suffering from heart failure. It is implanted as short-term treatment after surgery or while patients are waiting for a heart transplant. It assists in pumping blood from the lower chambers of the heart to the rest of the body. It generally includes tubes, an electronic controller and a power source. It is employed in destination therapies, bridge-to-transplant (BTT), bridge-to-recovery (BTR) and bridge-to-candidacy (BTC).

Request Free Sample Report:

Global Ventricular Assist Devices Market Trends:

Heart transplantation is an optimal surgical therapy utilized for end? stage heart failure (HF). It is increasingly becoming limited on account of the shortage of suitable heart donors and the widening gap between donors and recipients. This represents one of the significant factors propelling the global ventricular assist devices market growth. Apart from this, the rising prevalence of cardiovascular disorders (CVDs), such as hypertension, ventricular septal defect, heart failure and stroke, due to stressful and sedentary lifestyles and increasing consumption of fast food, is also strengthening the market growth. Furthermore, the leading manufacturers are using advanced technologies to develop miniature devices designed with infection control, which is anticipated to impel the market growth in the coming years. Looking forward, IMARC Group expects the global ventricular assist device market to grow at a CAGR of around 10% during 2021-2026.

Breakup by Product:

  • Left Ventricular Assist Device (LVAD)
  • Right Ventricular Assist Device (RVAD)
  • Biventricular Assist Device (BiVAD)
  • Others

Breakup by Flow Type:

  • Pulsatile Flow
  • Non-Pulsatile or Continuous Flow

Breakup by Product Type:

  • Implantable Ventricular Assist Devices
  • Non-implantable Ventricular Assist Devices

Breakup by Application:

  • Bridge-to-Transplant (BTT) Therapy
  • Destination Therapy
  • Bridge to Recovery and Bridge to Candidacy

Breakup by End-User:

  • Ambulatory Surgery Centers
  • Hospital
  • Others

Breakup by Region:

Region-wise, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa.

Competitive Landscape with Key Player:

  • Abbott Laboratories (ABT)
  • Abiomed, Inc.
  • Berlin Heart GmbH (Syscore GmbH)
  • BiVACOR, Inc.
  • Calon Cardio Technology Limited
  • Cardiacassist Inc. (LivaNova PLC)
  • CHF Solutions, Inc.
  • Jarvik Heart, Inc.
  • MAQUET GmbH (Getinge Group)
  • Medtronic Plc
  • Syncardia Systems LLC (Versa Capital Management LLC)
  • TandemLife (LivaNova Plc)
  • Terumo Corporation.

Ask Customization and Browse Full Report with TOC & List of Figure:

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Other Reports By IMARC Group:

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Reply